RU2001103135A - Вакцина против цирковируса и парвовируса свиней - Google Patents
Вакцина против цирковируса и парвовируса свинейInfo
- Publication number
- RU2001103135A RU2001103135A RU2001103135/13A RU2001103135A RU2001103135A RU 2001103135 A RU2001103135 A RU 2001103135A RU 2001103135/13 A RU2001103135/13 A RU 2001103135/13A RU 2001103135 A RU2001103135 A RU 2001103135A RU 2001103135 A RU2001103135 A RU 2001103135A
- Authority
- RU
- Russia
- Prior art keywords
- pig
- vaccine
- circovirus
- group
- antigen
- Prior art date
Links
- 241000282898 Sus scrofa Species 0.000 title claims 14
- 241001533384 Circovirus Species 0.000 title claims 11
- 229960005486 vaccines Drugs 0.000 title claims 11
- 241000125945 Protoparvovirus Species 0.000 title claims 4
- 239000000427 antigen Substances 0.000 claims 13
- 102000038129 antigens Human genes 0.000 claims 13
- 108091007172 antigens Proteins 0.000 claims 13
- 239000003814 drug Substances 0.000 claims 6
- 229940079593 drugs Drugs 0.000 claims 6
- 241000282887 Suidae Species 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 3
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims 2
- 208000009305 Pseudorabies Diseases 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000000890 antigenic Effects 0.000 claims 2
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 2
- 230000001717 pathogenic Effects 0.000 claims 2
- 201000010874 syndrome Diseases 0.000 claims 2
- 230000003612 virological Effects 0.000 claims 2
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 claims 1
- 241000271566 Aves Species 0.000 claims 1
- 241000178270 Canarypox virus Species 0.000 claims 1
- 206010008631 Cholera Diseases 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 206010022000 Influenza Diseases 0.000 claims 1
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 claims 1
- 108050006987 Poxvirus Proteins 0.000 claims 1
- 206010039088 Rhinitis atrophic Diseases 0.000 claims 1
- 241000700618 Vaccinia virus Species 0.000 claims 1
- 241000700647 Variola virus Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 201000008283 atrophic rhinitis Diseases 0.000 claims 1
- 230000002238 attenuated Effects 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 244000052769 pathogens Species 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
Claims (16)
1. Антигенный препарат против синдрома МСИМ, включающий антиген цирковируса свиней и антиген парвовируса свиней.
2. Препарат по п.1, включающий антиген цирковируса свиней типа II.
3. Препарат по п.2, в котором антиген цирковируса свиней типа II выбран из группы, состоящей из препаратов, депонированных в ЕСАСС со следующими реквизитами: инвентарный номер V97100219, инвентарный номер V97100218, инвентарный номер V97100217, инвентарный номер V98011608, инвентарный номер V98011609.
4. Препарат по любому из пп.1-3, в котором антиген цирковируса свиней и антиген парвовируса свиней включают, независимо друг от друга, антиген, выбранный из группы, состоящей из ослабленных живых цельных антигенов, инактивированных цельных антигенов, субъединичных антигенов, рекомбинантных живых векторов и ДНК-векторов.
5. Препарат по любому из пп.1-4, включающий дополнительно еще одну валентность, соответствующую другому патогену свиней.
6. Препарат по п.5, включающий еще одну валентность, выбранную из группы, состоящей из PRRS, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, E. coli, атрофического ринита, псевдобешенства, холеры свиней, свиного гриппа и их комбинаций.
7. Препарат по п.5, в котором дополнительная валентность означает PRRS.
8. Вакцина против синдрома МСИС, включающая эффективное количество антигенного препарата по любому из пп.1-7, в растворителе или наполнителе, приемлемом с ветеринарной точки зрения.
9. Вакцина по п.8, включающая адъювант, приемлемый с ветеринарной точки зрения.
10. Вакцина по п.8 или 9, включающая антигены нескольких цирковирусов свиней.
11. Вакцина по любому из пп.8-10, включающая антиген цирковируса, кодируемый открытой рамкой считывания цирковируса, выбранной из группы, состоящей из ORF 1-13.
12. Вакцина по п.11, включающая антиген цирковируса, кодируемый открытой рамкой считывания цирковируса, выбранной из группы, состоящей из ORF 4, 7, 10 и 13.
13. Вакцина по любому из пп.8-12, включающая экспрессионный вектор, выбранный из группы, состоящей из живых вирусов, способных размножаться в организме свиньи, но не патогенных для свиней, и ДНК-векторов, причем этот экспрессионный вектор содержит и экспрессирует указанный ORF.
14. Вакцина по п.13, в которой вирусный вектор выбран из группы, состоящей из герпесвирусов свиней, аденовирусов свиней и поксвирусов.
15. Вакцина по п.14, в которой вирусный вектор выбран из группы, состоящей из вируса болезни Aujeszky, вируса коровьей оспы, вируса оспы птиц, вируса оспы канареек и вируса оспы свиней.
16. Набор для вакцинации, включающий, в отдельных упаковках, вакцину против цирковируса свиней по любому из пп.8-15 и вакцину против парвовируса свиней.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808777A FR2781159B1 (fr) | 1998-07-06 | 1998-07-06 | Vaccin circovirus et parvovirus porcin |
FR98/08777 | 1998-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001103135A true RU2001103135A (ru) | 2003-06-20 |
RU2237492C2 RU2237492C2 (ru) | 2004-10-10 |
Family
ID=9528441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001103135A RU2237492C2 (ru) | 1998-07-06 | 1999-06-28 | Иммуногенная композиция, вызывающая иммунный ответ против парвовируса и цирковируса свиньи, вакцина против многосистемного синдрома истощения свиней (pmws) (варианты), набор для вакцинации и способ ее осуществления |
Country Status (22)
Country | Link |
---|---|
US (2) | US6217883B1 (ru) |
EP (1) | EP1094837B1 (ru) |
JP (2) | JP4749547B2 (ru) |
KR (1) | KR100730336B1 (ru) |
CN (1) | CN1168502C (ru) |
AT (1) | ATE452653T1 (ru) |
AU (1) | AU746234B2 (ru) |
BR (1) | BRPI9911870B8 (ru) |
CA (1) | CA2332627C (ru) |
CY (1) | CY1110290T1 (ru) |
DE (1) | DE69941843D1 (ru) |
DK (1) | DK1094837T3 (ru) |
ES (1) | ES2338616T3 (ru) |
FR (1) | FR2781159B1 (ru) |
HU (1) | HU227805B1 (ru) |
MX (1) | MXPA00012785A (ru) |
PL (1) | PL205299B1 (ru) |
PT (1) | PT1094837E (ru) |
RU (1) | RU2237492C2 (ru) |
TW (1) | TWI221774B (ru) |
UA (1) | UA72891C2 (ru) |
WO (1) | WO2000001409A2 (ru) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
US7192594B2 (en) * | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
US7211379B2 (en) * | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
UA78180C2 (ru) * | 1997-10-03 | 2007-03-15 | Меріаль | Кольцевой вирус свиньи, вакцины и диагностические реагенты |
FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
US20040062775A1 (en) * | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
PT2363488E (pt) * | 1997-12-11 | 2015-01-13 | Univ Belfast | Síndrome multi-sistémica do definhamento pós-desmame de porcos |
US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
ES2170622B1 (es) * | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
DE10044648A1 (de) * | 2000-09-08 | 2002-03-21 | Aventis Behring Gmbh | Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material |
MY148759A (en) | 2001-03-27 | 2013-05-31 | Univ Saskatchewan | Methods to culture circovirus |
US20030096377A1 (en) * | 2001-06-28 | 2003-05-22 | Virginia Tech Intellectual Properties, Inc. | Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2 |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
EP2390352A1 (en) | 2003-03-18 | 2011-11-30 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
US20040258700A1 (en) * | 2003-06-23 | 2004-12-23 | Frimann Tine Holland | Vaccine formulation with a preservative |
US20050214316A1 (en) | 2003-11-13 | 2005-09-29 | Brown Thomas P | Methods of characterizing infectious bursal disease virus |
EP1718770B1 (en) | 2004-02-19 | 2011-05-25 | The Governors of the University of Alberta | Leptin promoter polymorphisms and uses thereof |
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
ES2733428T3 (es) * | 2004-12-30 | 2019-11-29 | Boehringer Ingelheim Animal Health Usa Inc | Composiciones inmunogénicas frente a PCV2 y métodos para producir composiciones de este tipo |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
DE602006013117D1 (de) | 2005-04-25 | 2010-05-06 | Merial Ltd | Nipah-virus-impfstoffe |
TW200643171A (en) * | 2005-06-07 | 2006-12-16 | Temasek Life Sciences Lab Ltd | Porcine circovirus type 2 vaccines |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
KR100693077B1 (ko) * | 2005-11-03 | 2007-03-12 | 채찬희 | 돼지 복합 호흡기 질환 예방 및 치료용 생물학적 조성물 |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
EP2186823A1 (en) | 2005-11-14 | 2010-05-19 | Merial Limited | Gene therapy for renal failure |
PL1968630T3 (pl) | 2005-12-29 | 2018-08-31 | Boehringer Ingelheim Vetmedica, Inc. | Multiwalentne immunogenne kompozycje PCV2 |
CN104383526B (zh) | 2005-12-29 | 2018-09-18 | 贝林格尔.英格海姆维特梅迪卡有限公司 | Pcv2免疫原性组合物用于减轻猪临床症状的用途 |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
WO2008127279A2 (en) * | 2006-10-05 | 2008-10-23 | Cerebus Biologicals, Inc. | Methods for treating, preventing and diagnosing porcine ttv infection |
US20100136060A1 (en) * | 2006-11-22 | 2010-06-03 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing porcine circovirus-associated disease outbreaks |
US20100129397A1 (en) * | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
EP2094872B2 (en) | 2006-12-15 | 2020-02-19 | Boehringer Ingelheim Animal Health USA Inc. | Treatment of anti-PCV2 antibody seropositive pigs with PCV2 antigen |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
CN101294224B (zh) * | 2007-05-08 | 2011-04-06 | 深圳太太基因工程有限公司 | 一种用于检测猪细小病毒核苷酸片段的引物和探针序列 |
KR20100025529A (ko) * | 2007-05-30 | 2010-03-09 | 와이어쓰 엘엘씨 | 돼지 바이러스의 유전자를 발현하는 라쿤 폭스바이러스 |
US20090017064A1 (en) * | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
EP2225367A1 (en) * | 2007-12-21 | 2010-09-08 | Wyeth LLC | Methods and compositions for immunizing pigs against porcine circovirus |
US20110020394A1 (en) * | 2007-12-31 | 2011-01-27 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 orf2 virus like particle with foreign amino acid insertion |
EP2242511A4 (en) * | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS |
WO2009103037A1 (en) * | 2008-02-15 | 2009-08-20 | Boehringer Ingelheim Vetmedica, Inc. | Methods and compositions for reducing the impact of enteric diseases |
US7927586B2 (en) * | 2008-07-08 | 2011-04-19 | South Dakota State University | Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli |
CA2757030C (en) | 2009-04-03 | 2019-01-15 | Merial Limited | Vectors comprising newcastle disease viruses and compositions thereof |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
US8986706B2 (en) | 2010-08-31 | 2015-03-24 | Merial, Inc. | Newcastle disease virus vectored herpesvirus vaccines |
CN101947318B (zh) * | 2010-09-09 | 2012-09-05 | 扬州优邦生物制药有限公司 | 一种猪细小病毒灭活疫苗的制备方法 |
TWI442935B (zh) | 2010-12-22 | 2014-07-01 | Sbc Virbac Ltd | 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用 |
WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
EP2694677A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
AU2012240246A1 (en) | 2011-04-04 | 2013-05-09 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
KR102007444B1 (ko) | 2011-04-25 | 2019-08-06 | 어드밴스드 바이오사이언스 라보라토리즈, 인코포레이티드 | 절단형 hiv 피막 단백질(env), 이와 관련된 방법 및 조성물 |
EP2714077B1 (en) | 2011-06-01 | 2018-02-28 | Merial, Inc. | Needle-free administration of prrsv vaccines |
HUE035774T2 (en) | 2011-08-12 | 2018-05-28 | Merial Inc | Biological substances, in particular vaccines, preserved by vacuum |
UA113192C2 (xx) | 2011-12-06 | 2016-12-26 | Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2) | |
WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
CN105749273A (zh) * | 2012-01-13 | 2016-07-13 | 普莱柯生物工程股份有限公司 | 猪圆环病毒2型与猪细小病毒二联灭活疫苗及其制备方法 |
CN102961742A (zh) * | 2012-01-13 | 2013-03-13 | 普莱柯生物工程股份有限公司 | 猪圆环病毒2型与猪细小病毒二联灭活疫苗及其制备方法 |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
CN102719407B (zh) * | 2012-05-25 | 2013-09-04 | 中国农业科学院哈尔滨兽医研究所 | 猪细小病毒bq-c株及其在制备猪细小病毒灭活疫苗中的应用 |
WO2014164697A1 (en) | 2013-03-12 | 2014-10-09 | Merial Limited | Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof |
US9649370B2 (en) | 2013-05-08 | 2017-05-16 | Protatek International, Inc. | Vaccine for PCV2 and mycoplasma |
JP6821429B2 (ja) | 2013-09-25 | 2021-01-27 | ゾエティス・サービシーズ・エルエルシー | Pcv2b分岐ワクチン組成物及び使用方法 |
EA035265B1 (ru) | 2013-10-02 | 2020-05-21 | Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. | Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы |
CN110354258A (zh) | 2013-12-03 | 2019-10-22 | 英特维特国际股份有限公司 | 抗猪圆环病毒2型的疫苗 |
CN104250640A (zh) | 2014-08-22 | 2014-12-31 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CA2966191A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
CN105087506B (zh) * | 2015-03-20 | 2020-06-30 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用 |
US9944904B2 (en) | 2015-05-14 | 2018-04-17 | Merial Inc. | Method for porcine circovirus production and PCV2 vaccines |
AU2016282772B2 (en) | 2015-06-23 | 2019-09-05 | Boehringer Ingelheim Animal Health USA Inc. | PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof |
EP3432920A1 (en) | 2016-03-23 | 2019-01-30 | Intervet International B.V. | A vaccine for intradermal application against pcv2 and prrs virus infection |
CN106435016B (zh) * | 2016-08-30 | 2019-07-26 | 中国农业科学院兰州兽医研究所 | 一种快速显色一步法检测猪圆环病毒2型的lamp试剂盒 |
MX2019005136A (es) | 2016-11-03 | 2019-06-20 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna contra el parvovirus porcino y el virus del sindrome respiratorio reproductivo porcino y metodos de produccion de esta. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1538305A1 (ru) | 1987-07-21 | 1994-12-15 | Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР | Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней |
US5811103A (en) * | 1989-03-19 | 1998-09-22 | Akzo Nobel N.V. | Hog cholera virus vaccine and diagnostic |
ES2026827A6 (es) | 1991-03-26 | 1992-05-01 | Ercros Sa | Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino. |
FR2751224B1 (fr) * | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
UA78180C2 (ru) * | 1997-10-03 | 2007-03-15 | Меріаль | Кольцевой вирус свиньи, вакцины и диагностические реагенты |
US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
US6517843B1 (en) * | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
-
1998
- 1998-07-06 FR FR9808777A patent/FR2781159B1/fr not_active Expired - Lifetime
-
1999
- 1999-06-28 JP JP2000557855A patent/JP4749547B2/ja not_active Expired - Lifetime
- 1999-06-28 WO PCT/EP1999/004698 patent/WO2000001409A2/en active IP Right Grant
- 1999-06-28 BR BRPI9911870A patent/BRPI9911870B8/pt not_active IP Right Cessation
- 1999-06-28 HU HU0102770A patent/HU227805B1/hu unknown
- 1999-06-28 EP EP99932831A patent/EP1094837B1/en not_active Expired - Lifetime
- 1999-06-28 CN CNB998091316A patent/CN1168502C/zh not_active Expired - Lifetime
- 1999-06-28 KR KR1020017000182A patent/KR100730336B1/ko not_active IP Right Cessation
- 1999-06-28 PL PL345948A patent/PL205299B1/pl unknown
- 1999-06-28 ES ES99932831T patent/ES2338616T3/es not_active Expired - Lifetime
- 1999-06-28 MX MXPA00012785A patent/MXPA00012785A/es unknown
- 1999-06-28 DE DE69941843T patent/DE69941843D1/de not_active Expired - Lifetime
- 1999-06-28 UA UA2001020808A patent/UA72891C2/xx unknown
- 1999-06-28 AT AT99932831T patent/ATE452653T1/de active
- 1999-06-28 AU AU49077/99A patent/AU746234B2/en not_active Expired
- 1999-06-28 DK DK99932831.3T patent/DK1094837T3/da active
- 1999-06-28 CA CA2332627A patent/CA2332627C/en not_active Expired - Lifetime
- 1999-06-28 RU RU2001103135A patent/RU2237492C2/ru active
- 1999-06-28 PT PT99932831T patent/PT1094837E/pt unknown
- 1999-07-01 US US09/347,594 patent/US6217883B1/en not_active Expired - Lifetime
-
2000
- 2000-04-10 TW TW088111464A patent/TWI221774B/zh not_active IP Right Cessation
-
2001
- 2001-02-16 US US09/784,962 patent/US6953581B2/en not_active Expired - Lifetime
-
2010
- 2010-02-25 CY CY20101100181T patent/CY1110290T1/el unknown
- 2010-04-23 JP JP2010100018A patent/JP2010222359A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001103135A (ru) | Вакцина против цирковируса и парвовируса свиней | |
CA2332627A1 (en) | Porcine circovirus and parvovirus vaccine | |
Charlton et al. | Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine | |
CN1329513C (zh) | 抗猪生殖和呼吸疾病的多核苷酸疫苗制剂 | |
Taylor et al. | Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins | |
Taylor et al. | Recombinant fowlpox virus inducing protective immunity in non-avian species | |
Breitburd et al. | Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection | |
Taylor et al. | Fowlpox virus as a vector in non-avian species | |
Gagnon et al. | Adenoviral-expressed GP 5 of porcine respiratory and reproductive syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions | |
US20100150959A1 (en) | PCV 2-Based Methods and Compositions for the Treatment of Pigs | |
JP2018535251A (ja) | ブタサーコウイルス3型免疫原性組成物、その製造方法、およびその使用方法 | |
JP2005515162A5 (ru) | ||
AU2009236669B2 (en) | Chimeric porcine circovirus PCV2Gen-1Rep and uses thereof | |
JP5041445B2 (ja) | マイコプラズマprrsvに対するワクチン | |
RU2000111496A (ru) | Новые цирковирусы свиней, вакцины и реагенты для диагностики | |
Kheyar et al. | Alternative codon usage of PRRS virus ORF5 gene increases eucaryotic expression of GP5 glycoprotein and improves immune response in challenged pigs | |
US10106819B2 (en) | Recombinant swinepox virus and vaccines | |
Wasmoen et al. | Protection of cats from infectious peritonitis by vaccination with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus | |
Roques et al. | Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens | |
Boulanger et al. | Comparison of the susceptibility of the red fox (Vulpes vulpes) to a vaccinia-rabies recombinant virus and to cowpox virus | |
Han et al. | Immunogenicity of recombinant vaccinia virus vaccines co-expressing GP3/GP5 of European PRRSV and Cap protein of PCV2 in pigs | |
Boyle et al. | Comparison of field and vaccine strains of Australian fowlpox viruses | |
Gai et al. | Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine | |
KATAYAMA et al. | Protective effect of glycoprotein gC-rich antigen against pseudorabies virus | |
Kumar et al. | Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models |